Year |
Citation |
Score |
2018 |
Kamdar K, Johnson AMF, Chac D, Myers K, Kulur V, Truevillian K, DePaolo RW. Innate Recognition of the Microbiota by TLR1 Promotes Epithelial Homeostasis and Prevents Chronic Inflammation. Journal of Immunology (Baltimore, Md. : 1950). PMID 29794015 DOI: 10.4049/jimmunol.1701216 |
0.419 |
|
2016 |
Kamdar K, Khakpour S, Chen J, Leone V, Brulc J, Mangatu T, Antonopoulos DA, Chang EB, Kahn SA, Kirschner BS, Young G, DePaolo RW. Genetic and Metabolic Signals during Acute Enteric Bacterial Infection Alter the Microbiota and Drive Progression to Chronic Inflammatory Disease. Cell Host & Microbe. 19: 21-31. PMID 26764594 DOI: 10.1016/J.Chom.2015.12.006 |
0.314 |
|
2015 |
Nguyen V, Pearson K, Kim JH, Kamdar K, DePaolo RW. Retinoic acid can exacerbate T cell intrinsic TLR2 activation to promote tolerance. Plos One. 10: e0118875. PMID 25826367 DOI: 10.1371/Journal.Pone.0118875 |
0.314 |
|
2013 |
Sugiura Y, Kamdar K, Khakpour S, Young G, Karpus WJ, DePaolo RW. TLR1-induced chemokine production is critical for mucosal immunity against Yersinia enterocolitica. Mucosal Immunology. 6: 1101-9. PMID 23443468 DOI: 10.1038/Mi.2013.5 |
0.578 |
|
2013 |
Kamdar K, Nguyen V, DePaolo RW. Toll-like receptor signaling and regulation of intestinal immunity. Virulence. 4: 207-12. PMID 23334153 DOI: 10.4161/viru.23354 |
0.426 |
|
2012 |
DePaolo RW, Kamdar K, Khakpour S, Sugiura Y, Wang W, Jabri B. A specific role for TLR1 in protective T(H)17 immunity during mucosal infection. The Journal of Experimental Medicine. 209: 1437-44. PMID 22778390 DOI: 10.1084/jem.20112339 |
0.461 |
|
2011 |
DePaolo RW, Abadie V, Tang F, Fehlner-Peach H, Hall JA, Wang W, Marietta EV, Kasarda DD, Waldmann TA, Murray JA, Semrad C, Kupfer SS, Belkaid Y, Guandalini S, Jabri B. Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature. 471: 220-4. PMID 21307853 DOI: 10.1038/Nature09849 |
0.418 |
|
2009 |
Elhofy A, Depaolo RW, Lira SA, Lukacs NW, Karpus WJ. Mice deficient for CCR6 fail to control chronic experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 213: 91-9. PMID 19535153 DOI: 10.1016/J.Jneuroim.2009.05.011 |
0.619 |
|
2008 |
Depaolo RW, Tang F, Kim I, Han M, Levin N, Ciletti N, Lin A, Anderson D, Schneewind O, Jabri B. Toll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis. Cell Host & Microbe. 4: 350-61. PMID 18854239 DOI: 10.1016/J.Chom.2008.09.004 |
0.472 |
|
2006 |
DeBord KL, Anderson DM, Marketon MM, Overheim KA, DePaolo RW, Ciletti NA, Jabri B, Schneewind O. Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV. Infection and Immunity. 74: 4910-4. PMID 16861680 DOI: 10.1128/Iai.01860-05 |
0.423 |
|
2005 |
Depaolo RW, Lathan R, Rollins BJ, Karpus WJ. The chemokine CCL2 is required for control of murine gastric Salmonella enterica infection. Infection and Immunity. 73: 6514-22. PMID 16177325 DOI: 10.1128/Iai.73.10.6514-6522.2005 |
0.584 |
|
2005 |
Marketon MM, DePaolo RW, DeBord KL, Jabri B, Schneewind O. Plague bacteria target immune cells during infection. Science (New York, N.Y.). 309: 1739-41. PMID 16051750 DOI: 10.1126/Science.1114580 |
0.331 |
|
2005 |
Overheim KA, Depaolo RW, Debord KL, Morrin EM, Anderson DM, Green NM, Brubaker RR, Jabri B, Schneewind O. LcrV plague vaccine with altered immunomodulatory properties. Infection and Immunity. 73: 5152-9. PMID 16041032 DOI: 10.1128/Iai.73.8.5152-5159.2005 |
0.394 |
|
2004 |
DePaolo RW, Lathan R, Karpus WJ. CCR5 regulates high dose oral tolerance by modulating CC chemokine ligand 2 levels in the GALT. Journal of Immunology (Baltimore, Md. : 1950). 173: 314-20. PMID 15210789 DOI: 10.4049/Jimmunol.173.1.314 |
0.61 |
|
2003 |
DePaolo RW, Rollins BJ, Kuziel W, Karpus WJ. CC chemokine ligand 2 and its receptor regulate mucosal production of IL-12 and TGF-beta in high dose oral tolerance. Journal of Immunology (Baltimore, Md. : 1950). 171: 3560-7. PMID 14500652 DOI: 10.4049/Jimmunol.171.7.3560 |
0.631 |
|
Show low-probability matches. |